Exciva GmbH’s EUR 9 Million Series A Funding Round

Bird & Bird has advised Exciva GmbH on the deal.Exciva GmbH, a clinical biotech company which is developing a novel therapy for the treatment of agitation…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Giulia Di Palma

Author: Giulia Di Palma

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here